Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cronos Group Inc T.CRON

Alternate Symbol(s):  CRON

Healthcare Cannabis
Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is... see more

Recent & Breaking News (TSX:CRON)

Canadian Listed Cannabis Stocks Forge Ahead In Booming Legal Marijuana Market

PR Newswire November 29, 2016

Cronos Group Provides Operational Update and Q3 Financial Results

MarketWire Canada November 29, 2016

Cronos Group Grants Stock Options

MarketWire Canada November 21, 2016

Cronos Group Enters Agreement With XIB Consulting

MarketWire Canada November 16, 2016

Cronos Group Receives Liquidity From Non-Core Asset

MarketWire Canada November 1, 2016

PharmaCan Announces Closing of Third Tranche of Non-Brokered Private Placement

MarketWire Canada September 8, 2016

PharmaCan Acquires Peace Naturals Project Inc.

MarketWire Canada September 6, 2016

PharmaCan Announces Closing of Second Tranche of Non-Brokered Private Placement

MarketWire Canada August 31, 2016

PharmaCan Announces In The Zone MMPR License Renewal and Whistler Medical Marijuana MMPR License Amendment to Sell Cannabis Oil

Marketwired March 1, 2016

PharmaCan Served With Statement of Claim

Marketwired February 26, 2016

Pharmacan Announces Restructuring of Its Board of Directors

Marketwired January 19, 2016

PharmaCan Provides Update on the Closing of Sale of Shares of Peace Naturals

Marketwired January 13, 2016

PharmaCan Announces In The Zone Produce Ltd. Receives Approval for MMPR License Amendment From Health Canada

Marketwired December 22, 2015

PharmaCan Provides Update on the Closing of Sale of Shares of Peace Naturals

Marketwired December 18, 2015

Medical Marijuana update: Supreme gets a date, Aurora gets a license

Chris Parry December 8, 2015

Canopy Growth Corporation (V.CGC) looks to buy Peace Naturals – or sue it into the ground

Chris Parry November 30, 2015

PharmaCan Notified of Update on the Closing of Sale of Shares of Peace Naturals

Marketwired November 27, 2015

PharmaCan Announces Adoption of Shareholder Rights Plan and Changes to the Board of Directors

Marketwired November 9, 2015

PhamaCan Notified of Update on the Closing of Sale of Shares of Peace Naturals

Marketwired November 6, 2015

PhamaCan Announces Notice of Exercising Tag Along Rights to Participate in the Sale of All of Its Shares in Peace Naturals

Marketwired November 3, 2015